Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)

Exclusion Criteria

• •Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids
• •Chronic obstructive pulmonary disease (COPD)
• •Hospitalization within previous four weeks from baseline
• •Hospitalization due to asthma within the last twelve months
• •Asthma exacerbation within two months previous to baseline
• •History of almost fatal asthma at any moment
• •Pregnancy, breast feeding, intention to become pregnant during the course of the study or lack of safe contraception in pre-menopausal women
• •Exacerbation of asthma within 2 months prior to entry into the baseline period
• •Use of systemic steroids up to 2 months (injectable depot steroids 6 months) before entry into the baseline period, or more than 3 times during the last 6 months